At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
Robotic Endovascular Proceduredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of Effectiveness and Safety of the CorPath® GRX System in Endovascular Embolization Procedures of Cerebral Aneurysms
In Brief
A clinical study evaluating Robotic Endovascular Procedure for Intracranial Aneurysm and 2 related conditions. Completed, enrolled 120 participants across 10 sites in 6 countries.
Detailed Summary
The primary objective of this study is to evaluate the effectiveness and safety of robotic-assisted endovascular embolization procedures compared to objective performance criteria for traditional, manual operation based on the scientific literature.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntracranial Aneurysm, Subarachnoid Hemorrhage, Headache
CountriesAustralia, Austria, Canada, France, Spain, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartAug 2020
Primary CompletionApr 2022
Study CompletionOct 2022
TodayJul 2026
First PostedJan 22, 2020
Enrollment StartAug 21, 2020
Primary CompletionApr 23, 2022
Study CompletionOct 12, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 6.4 years ago
Interventions
Robotic Endovascular Proceduredevice
After providing written informed consent, subjects with cerebral aneurysms may have their aneurysm treated using the CorPath GRX System.